Extracellular vesicle analysis of plasma allows differential diagnosis of atypical pancreatic serous cystadenoma

• Published in: Scientific reports Vol. 13; no. 1; p. 10969
• Main Authors: Yang, Katherine S., O’Shea, Aileen, Zelga, Piotr, Liss, Andrew S., Del Castillo, Carlos Fernandez, Weissleder, Ralph
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 06-07-2023; Nature Publishing Group; Nature Portfolio
• Subjects: 692/53/2421; 692/699/1503; Asymptomatic; Biomarkers; Biopsy; Cysts; Cytokeratin; Decision making; Differential diagnosis; Extracellular vesicles; Hospitals; Humanities and Social Sciences; Lesions; multidisciplinary; Pancreas; Plasma; Proteins; Science; Science (multidisciplinary); Tumors; Vimentin
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-37966-5

Increased use of cross-sectional imaging has resulted in frequent detection of incidental cystic pancreatic lesions. Serous cystadenomas (SCAs) are benign cysts that do not require surgical intervention unless symptomatic. Unfortunately, up to half of SCAs do not have typical imaging findings (“atypical SCAs”), overlap with potentially malignant precursor lesions, and thus pose a diagnostic challenge. We tested whether the analysis of circulating extracellular vesicle (EV) biomarkers using a digital EV screening technology (DEST) could enhance the discrimination of cystic pancreatic lesions and avoid unnecessary surgical intervention in these atypical SCAs. Analysis of 25 different protein biomarkers in plasma EV from 68 patients identified a putative biomarker signature of Das-1, Vimentin, Chromogranin A, and CAIX with high discriminatory power (AUC of 0.99). Analysis of plasma EV for multiplexed markers may thus be helpful in clinical decision-making.